Federated Hermes Inc. Invests $283,000 in American Vanguard Corporation (NYSE:AVD)

Key Points

• Federated Hermes Inc. has acquired 64,357 shares of American Vanguard Corporation, valued at approximately $283,000, during the first quarter of the year.
• Institutional investors collectively own 79.04% of American Vanguard's stock, with notable purchases made by firms like Topline Capital Management and Cubist Systematic Strategies.
• Analysts have recently downgraded American Vanguard's stock, with Lake Street Capital reducing its price target from $14.00 to $12.00 and changing the rating from "buy" to "hold."

Federated Hermes Inc. acquired a new position in shares of American Vanguard Corporation (NYSE:AVD - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 64,357 shares of the basic materials company's stock, valued at approximately $283,000. Federated Hermes Inc. owned 0.22% of American Vanguard as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC raised its stake in American Vanguard by 134.7% during the first quarter. CWM LLC now owns 9,425 shares of the basic materials company's stock worth $41,000 after acquiring an additional 5,410 shares in the last quarter. Cerity Partners LLC bought a new position in American Vanguard in the 1st quarter valued at approximately $48,000. Bayesian Capital Management LP bought a new position in American Vanguard in the 4th quarter valued at approximately $54,000. Susquehanna Fundamental Investments LLC bought a new position in American Vanguard in the 4th quarter valued at approximately $68,000. Finally, Wells Fargo & Company MN raised its holdings in American Vanguard by 23.8% in the 4th quarter. Wells Fargo & Company MN now owns 14,952 shares of the basic materials company's stock valued at $69,000 after buying an additional 2,875 shares during the last quarter. Institutional investors own 79.04% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Wall Street Zen lowered shares of American Vanguard from a "buy" rating to a "hold" rating in a report on Sunday. Lake Street Capital dropped their price objective on shares of American Vanguard from $14.00 to $12.00 and set a "buy" rating for the company in a report on Monday, June 9th.

American Vanguard Trading Up 1.6%

NYSE:AVD traded up $0.09 on Thursday, reaching $5.36. 110,368 shares of the stock traded hands, compared to its average volume of 236,322. The firm has a market capitalization of $152.24 million, a price-to-earnings ratio of -1.20 and a beta of 1.23. The company's 50 day moving average is $4.07 and its 200-day moving average is $4.44. The company has a current ratio of 1.91, a quick ratio of 1.00 and a debt-to-equity ratio of 0.82. American Vanguard Corporation has a 1-year low of $3.28 and a 1-year high of $6.68.

American Vanguard (NYSE:AVD - Get Free Report) last released its earnings results on Thursday, July 31st. The basic materials company reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.11) by $0.08. The business had revenue of $129.31 million during the quarter, compared to the consensus estimate of $130.00 million. American Vanguard had a negative net margin of 23.72% and a negative return on equity of 26.21%.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.